Donald E. Morel Jr.
Chief Executive Officer, West Pharmaceutical Services (United States).
Companies
- Stevanato GroupBoard member Mar 18, 2026 to now1
- Catalent Pharma SolutionsBoard member Nov 17, 2015 to Dec 18, 20242
- INTEGRA LIFESCIENCES HOLDINGS CORPBoard member Aug 27, 2013 to May 17, 20223
- West Pharmaceutical Services (United States)Chief executive officer Jan 3, 2006 to Jul 1, 20154
- West Pharmaceutical Services (United States)Chair Jan 3, 2006 to Jul 1, 20154
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- INTEGRA LIFESCIENCES HOLDINGS CORP IART55,753 shares5$748.2K at $13.42May 13, 2022
Stevanato Group STVN37,424 shares6$707.5K at $18.91Jun 15, 2026
Catalent Pharma Solutions CTLT0 shares7Dec 18, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 15, 2026Sold 1,493 shares at $17.09 of Stevanato Group6
- Jun 12, 2026Granted 4,975 shares of Stevanato Group6
- Dec 18, 2024Returned to company 70,118 shares of Catalent Pharma Solutions7
- Oct 30, 2024Granted 4,663 shares of Catalent Pharma Solutions8
- Oct 27, 2023Granted 6,993 shares of Catalent Pharma Solutions9
- Oct 27, 2022Granted 4,149 shares of Catalent Pharma Solutions10
- May 13, 2022Granted 3,456 shares of INTEGRA LIFESCIENCES HOLDINGS CORP5
- Oct 28, 2021Granted 1,402 shares of Catalent Pharma Solutions11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARStevanato Group, Board member
- 2
- 3
- 4
- 5
- 6
- 7
- 8SEC EDGARForm 4 filed Nov 1, 2024
- 9SEC EDGARForm 4 filed Oct 31, 2023
- 10SEC EDGARForm 4 filed Oct 31, 2022
- 11SEC EDGARForm 4 filed Nov 1, 2021